Literature DB >> 2535728

Purification and properties of poliovirus RNA polymerase expressed in Escherichia coli.

S J Plotch1, O Palant, Y Gluzman.   

Abstract

A cDNA clone encoding the RNA polymerase of poliovirus has been expressed in Escherichia coli under the transcriptional control of a T7 bacteriophage promoter. The poliovirus enzyme was designed to contain only a single additional amino acid, the N-terminal methionine. The recombinant enzyme has been purified to near homogeneity, and polyclonal antibodies have been prepared against it. The enzyme exhibits poly(A)-dependent oligo(U)-primed poly(U) polymerase activity as well as RNA polymerase activity. In the presence of an oligo(U) primer, the enzyme catalyzes the synthesis of a full-length copy of either poliovirus or globin RNA templates. In the absence of added primer, RNA products up to twice the length of the template are synthesized. When incubated in the presence of a single nucleoside triphosphate, [alpha-32P]UTP, the enzyme catalyzes the incorporation of radioactive label into template RNA. These results are discussed in light of previously proposed models of poliovirus RNA synthesis in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535728      PMCID: PMC247675     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Mechanism of in vitro synthesis of covalently linked dimeric RNA molecules by the poliovirus replicase.

Authors:  J M Lubinski; G Kaplan; V R Racaniello; A Dasgupta
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

2.  The host protein required for in vitro replication of poliovirus is a protein kinase that phosphorylates eukaryotic initiation factor-2.

Authors:  C D Morrow; G F Gibbons; A Dasgupta
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

3.  Lack of evidence for VPg priming of poliovirus RNA synthesis in the host factor-dependent in vitro replicase reaction.

Authors:  N C Andrews; D Baltimore
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

4.  Anti-VPg antibody precipitation of product RNA synthesized in vitro by the poliovirus polymerase and host factor is mediated by VPg on the poliovirion RNA template.

Authors:  D C Young; B M Dunn; G J Tobin; J B Flanegan
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

5.  Requirement of 3'-terminal poly(adenylic acid) for the infectivity of poliovirus RNA.

Authors:  D H Spector; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

6.  Antibody to a synthetic nonapeptide corresponding to the NH2 terminus of poliovirus genome-linked protein VPg reacts with native VPg and inhibits in vitro replication of poliovirus RNA.

Authors:  C D Morrow; A Dasgupta
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

7.  Poliovirus RNA-dependent RNA polymerase and host cell protein synthesize product RNA twice the size of poliovirion RNA in vitro.

Authors:  D C Young; D M Tuschall; J B Flanegan
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

8.  Poliovirus replicase stimulation by terminal uridylyl transferase.

Authors:  N C Andrews; D Levin; D Baltimore
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

9.  Purification of a terminal uridylyltransferase that acts as host factor in the in vitro poliovirus replicase reaction.

Authors:  N C Andrews; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

10.  Versatile expression vectors for high-level synthesis of cloned gene products in Escherichia coli.

Authors:  R Crowl; C Seamans; P Lomedico; S McAndrew
Journal:  Gene       Date:  1985       Impact factor: 3.688

View more
  45 in total

1.  Oligomeric structures of poliovirus polymerase are important for function.

Authors:  S D Hobson; E S Rosenblum; O C Richards; K Richmond; K Kirkegaard; S C Schultz
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

2.  Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg.

Authors:  A V Paul; E Rieder; D W Kim; J H van Boom; E Wimmer
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Primer-dependent synthesis by poliovirus RNA-dependent RNA polymerase (3D(pol)).

Authors:  V Rodriguez-Wells; S J Plotch; J J DeStefano
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

4.  Gliotoxin: inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol.

Authors:  P L Rodriguez; L Carrasco
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNA-dependent RNA polymerase.

Authors:  Laura L Marcotte; Amanda B Wass; David W Gohara; Harsh B Pathak; Jamie J Arnold; David J Filman; Craig E Cameron; James M Hogle
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

6.  Poliovirus protein 3AB displays nucleic acid chaperone and helix-destabilizing activities.

Authors:  Jeffrey J DeStefano; Oduyebo Titilope
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  Multiple isoelectric forms of poliovirus RNA-dependent RNA polymerase: evidence for phosphorylation.

Authors:  L J Ransone; A Dasgupta
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol.

Authors:  S J Plotch; O Palant
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Biochemical and genetic studies of the initiation of human rhinovirus 2 RNA replication: purification and enzymatic analysis of the RNA-dependent RNA polymerase 3D(pol).

Authors:  K Gerber; E Wimmer; A V Paul
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Poliovirus infection enhances the formation of two ribonucleoprotein complexes at the 3' end of viral negative-strand RNA.

Authors:  H H Roehl; B L Semler
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.